Quantum Computing in Drug Discovery Market Size, Share, Scope Report 2026 to 2035
Market Segmentation:
Quantum Computing in Drug Discovery Market by Type of Offering-
• Hardware
• Service
• Platform / Software
Quantum Computing in Drug Discovery Market by Drug Discovery Steps-
• Target Identification / Validation
• Hit Generation / Lead Identification
• Lead Optimisation
Quantum Computing in Drug Discovery Market by Target Therapeutic Area-
• Oncological Disorders
• Cardiovascular Disorders
• Musculoskeletal Disorders
• Neurological Disorders
• Respiratory Disorders
• Immunological Disorders
• Gastrointestinal Disorders
• Endocrine Disorders
• Ophthalmological Disorders
• Blood-related Disorders
• Dermatological Disorders
• Infectious Diseases
• Urinary Disorders
Quantum Computing in Drug Discovery Market by End Users-
• Pharma and Biotech Companies
• CROs
• Research and Academic Institutions
Quantum Computing in Drug Discovery Market by Region-
North America-
• US
• Canada
Europe-
• UK
• Germany
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• South Korea
• India
• Australia
• Rest of Asia-Pacific
Latin America-
• Brazil
• Mexico
• Argentina
Middle East and Africa (MEA)-
Saudi Arabia
UAE
Egypt
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Quantum Computing in Drug Discovery Market Snapshot
Chapter 4. Global Quantum Computing in Drug Discovery Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter’s Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ Mn), 2026–2035
4.8. Market Penetration & Growth Prospect Mapping (US$ Mn), 2025–2035
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2025)
4.10. Use/Impact of AI on Quantum Computing in Drug Discovery Market
Chapter 5. Quantum Computing in Drug Discovery Market Segmentation 1: By Type of Offering, Estimates & Trend Analysis
5.1. Market Share by Type of Offering, 2025 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts (2022–2035)
5.2.1. Hardware
5.2.2. Service
5.2.3. Platform / Software
Chapter 6. Quantum Computing in Drug Discovery Market Segmentation 2: By Drug Discovery Steps, Estimates & Trend Analysis
6.1. Market Share by Drug Discovery Steps, 2025 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts (2022–2035)
6.2.1. Target Identification / Validation
6.2.2. Hit Generation / Lead Identification
6.2.3. Lead Optimisation
Chapter 7. Quantum Computing in Drug Discovery Market Segmentation 3: By Target Therapeutic Area, Estimates & Trend Analysis
7.1. Market Share by Therapeutic Area, 2025 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts (2022–2035)
7.2.1. Oncological Disorders
7.2.2. Cardiovascular Disorders
7.2.3. Musculoskeletal Disorders
7.2.4. Neurological Disorders
7.2.5. Respiratory Disorders
7.2.6. Immunological Disorders
7.2.7. Gastrointestinal Disorders
7.2.8. Endocrine Disorders
7.2.9. Ophthalmological Disorders
7.2.10. Blood-related Disorders
7.2.11. Dermatological Disorders
7.2.12. Infectious Diseases
7.2.13. Urinary Disorders
Chapter 8. Quantum Computing in Drug Discovery Market Segmentation 4: By End User, Estimates & Trend Analysis
8.1. Market Share by End User, 2025 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts (2022–2035)
8.2.1. Pharma and Biotech Companies
8.2.2. CROs
8.2.3. Research and Academic Institutions
Chapter 9. Quantum Computing in Drug Discovery Market Segmentation 5: By Geography, Estimates & Trend Analysis
9.1. Market Share by Geography, 2025 & 2035
9.2. Market Size (Value US$ Mn) & Forecasts (2022–2035)
9.2.1. North America
9.2.2. Europe
9.2.3. Asia-Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
Chapter 10. Quantum Computing in Drug Discovery Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. Global Quantum Computing in Drug Discovery Market,
Regional Snapshot (2025 & 2035)
10.2. North America
10.2.1. North America Quantum Computing in Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022–2035
10.2.1.1. U.S.
10.2.1.2. Canada
10.2.2. North America Quantum Computing in Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Type of Offering, 2022–2035
10.2.3. North America Quantum Computing in Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Drug Discovery Steps, 2022–2035
10.2.4. North America Quantum Computing in Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2022–2035
10.2.5. North America Quantum Computing in Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by End User, 2022–2035
10.3. Europe
10.3.1. Europe Quantum Computing in Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022–2035
10.3.1.1. U.K.
10.3.1.2. Germany
10.3.1.3. France
10.3.1.4. Italy
10.3.1.5. Spain
10.3.1.6. Rest of Europe
10.3.2. Europe Quantum Computing in Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Type of Offering, 2022–2035
10.3.3. Europe Quantum Computing in Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Drug Discovery Steps, 2022–2035
10.3.4. Europe Quantum Computing in Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2022–2035
10.3.5. Europe Quantum Computing in Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by End User, 2022–2035
10.4. Asia Pacific
10.4.1. Asia Pacific Quantum Computing in Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022–2035
10.4.1.1. China
10.4.1.2. Japan
10.4.1.3. South Korea
10.4.1.4. India
10.4.1.5. Australia
10.4.1.6. Rest of Asia Pacific
10.4.2. Asia Pacific Quantum Computing in Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Type of Offering, 2022–2035
10.4.3. Asia Pacific Quantum Computing in Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Drug Discovery Steps, 2022–2035
10.4.4. Asia Pacific Quantum Computing in Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2022–2035
10.4.5. Asia Pacific Quantum Computing in Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by End User, 2022–2035
10.5. Latin America
10.5.1. Latin America Quantum Computing in Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022–2035
10.5.1.1. Brazil
10.5.1.2. Mexico
10.5.1.3. Argentina
10.5.2. Latin America Quantum Computing in Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Type of Offering, 2022–2035
10.5.3. Latin America Quantum Computing in Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Drug Discovery Steps, 2022–2035
10.5.4. Latin America Quantum Computing in Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2022–2035
10.5.5. Latin America Quantum Computing in Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by End User, 2022–2035
10.6. Middle East & Africa
10.6.1. Middle East & Africa Quantum Computing in Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022–2035
10.6.1.1. Saudi Arabia
10.6.1.2. UAE
10.6.1.3. Egypt
10.6.2. Middle East & Africa Quantum Computing in Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Type of Offering, 2022–2035
10.6.3. Middle East & Africa Quantum Computing in Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Drug Discovery Steps, 2022–2035
10.6.4. Middle East & Africa Quantum Computing in Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2022–2035
10.6.5. Middle East & Africa Quantum Computing in Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by End User, 2022–2035
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions / Strategic Alliances
11.2. Company Profiles
11.2.1. IBM
11.2.2. IonQ
11.2.3. Microsoft
11.2.4. PASQAL
11.2.5. Rigetti Computing
11.2.6. Riverlane
11.2.7. Xanadu
11.2.8. Infleqtion
11.2.9. Quandela
11.2.10. Classiq
11.2.11. QuEra Computing
11.2.12. D-Wave Systems
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Quantum Computing in Drug Discovery Market Size is valued at USD 318.14 Mn in 2025 and is predicted to reach USD 1,804.98 Mn by the year 2035
Quantum Computing in Drug Discovery Market is expected to grow at a 19.1% CAGR during the forecast period for 2026 to 2035.
Raízen, Aemetis, Inc., California Bioenergy LLC, Vanguard Renewables Holdings, LLC, EnviTec Biogas AG, BTS Biogas Srl, Sun’Agri, Nexamp, Inc., OYA Solar Corp., Q ENERGY Solutions SE, Husk Power Systems
Quantum Computing in Drug Discovery Market is segmented into Type of Farming Entity, Type of Farm, Energy Type and By Region
North America region is leading the Quantum Computing in Drug Discovery Market.